Sun Pharmaceutical Industries Ltd. closed 16.18% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even ...

Sun Pharmaceutical Industries Ltd. closed 14.82% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Citi Research said it's for the good to avoid Lupin Ltd. and Aurobindo Pharma Ltd. which have heavy generic drugs portfolios.

The US is India’s largest export market for pharmaceuticals, accounting for over 30% of overall pharma exports in FY23-24 at $8.7 billion ...

Pharmaceutical stocks closed lower on Wednesday due to US President Trump's announcement of potential tariffs on auto, semiconductor, and pharmaceutical imports. Dr Reddy's, Zydus Lifesciences, ...

US President Donald Trump’s plan to introduce 25% tariff on imports of automobiles, semiconductors, and pharma could be bad ...

Earlier this week, Sun Pharma MD Dilip Shanghvi told ET Now that tariffs, if imposed, will be passed on to consumers. Pharma stocks have lost about 12% so far this year, while the benchmark Nifty ...

Trump’s tariff threats have sent shockwaves through Indian pharma stocks, but analysts argue the real casualty could be the US healthcare system. With India supplying nearly half of US generics, ...